Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes

Ali A. El Solh, Morohunfolu E. Akinnusi, Misha Peter, Ilya Berim, Marcus J. Schultz, Lilibeth Pineda

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective: To investigate the potential role of serum and alveolar soluble triggering receptor expressed on myeloid cells (sTREM-1) as a biological marker of pulmonary aspiration syndromes. Design: Prospective cohort study. Setting: University-affiliated intensive care unit. Patients: Seventy-five patients with pulmonary aspiration and 13 controls receiving mechanical ventilation. Interventions: Blood and bronchoalveolar lavage (BAL) fluid samples were collected on enrollment. Soluble TREM-1 levels were measured by an enzyme-linked immunosorbent assay. Measurements and results: Thirty-eight of 75 participants had documented BAL culture-positive pulmonary aspiration. While circulating levels of sTREM-1 were comparable between those with aspiration syndromes (19.81 ± 12.09 pg/ml) and controls (15.96 ± 11.16 pg/ml) (p = 0.27), the alveolar levels of sTREM-1 were higher in patients with culture-positive pulmonary aspiration (344.41 ± 152.82 pg/ml) compared with those culture-negative pulmonary aspiration (142.76 ± 89.88 pg/ml; p <0.001). A cut-off value of 250 pg/ml for alveolar sTREM-1 achieved a sensitivity of 65.8% (95% CI 48.6-80.4) and a specificity of 91.9% (95% CI 78.1-98.2) with an area under the curve of 0.87 (95% CI 0.78-0.94). Conclusions: Alveolar sTREM-1 levels can be a potential biomarker for distinguishing BAL culture-positive from BAL culture-negative pulmonary aspiration.

Original languageEnglish
Pages (from-to)1012-1019
Number of pages8
JournalIntensive Care Medicine
Volume34
Issue number6
DOIs
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Myeloid Cells
Lung
Bronchoalveolar Lavage
Biomarkers
Bronchoalveolar Lavage Fluid
Artificial Respiration
Area Under Curve
Intensive Care Units
Cohort Studies
Enzyme-Linked Immunosorbent Assay
Prospective Studies
Serum

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Cite this

Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. / El Solh, Ali A.; Akinnusi, Morohunfolu E.; Peter, Misha; Berim, Ilya; Schultz, Marcus J.; Pineda, Lilibeth.

In: Intensive Care Medicine, Vol. 34, No. 6, 06.2008, p. 1012-1019.

Research output: Contribution to journalArticle

El Solh, AA, Akinnusi, ME, Peter, M, Berim, I, Schultz, MJ & Pineda, L 2008, 'Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes', Intensive Care Medicine, vol. 34, no. 6, pp. 1012-1019. https://doi.org/10.1007/s00134-008-1087-7
El Solh, Ali A. ; Akinnusi, Morohunfolu E. ; Peter, Misha ; Berim, Ilya ; Schultz, Marcus J. ; Pineda, Lilibeth. / Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. In: Intensive Care Medicine. 2008 ; Vol. 34, No. 6. pp. 1012-1019.
@article{2cba1064170246b08f27b2343dce8419,
title = "Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes",
abstract = "Objective: To investigate the potential role of serum and alveolar soluble triggering receptor expressed on myeloid cells (sTREM-1) as a biological marker of pulmonary aspiration syndromes. Design: Prospective cohort study. Setting: University-affiliated intensive care unit. Patients: Seventy-five patients with pulmonary aspiration and 13 controls receiving mechanical ventilation. Interventions: Blood and bronchoalveolar lavage (BAL) fluid samples were collected on enrollment. Soluble TREM-1 levels were measured by an enzyme-linked immunosorbent assay. Measurements and results: Thirty-eight of 75 participants had documented BAL culture-positive pulmonary aspiration. While circulating levels of sTREM-1 were comparable between those with aspiration syndromes (19.81 ± 12.09 pg/ml) and controls (15.96 ± 11.16 pg/ml) (p = 0.27), the alveolar levels of sTREM-1 were higher in patients with culture-positive pulmonary aspiration (344.41 ± 152.82 pg/ml) compared with those culture-negative pulmonary aspiration (142.76 ± 89.88 pg/ml; p <0.001). A cut-off value of 250 pg/ml for alveolar sTREM-1 achieved a sensitivity of 65.8{\%} (95{\%} CI 48.6-80.4) and a specificity of 91.9{\%} (95{\%} CI 78.1-98.2) with an area under the curve of 0.87 (95{\%} CI 0.78-0.94). Conclusions: Alveolar sTREM-1 levels can be a potential biomarker for distinguishing BAL culture-positive from BAL culture-negative pulmonary aspiration.",
author = "{El Solh}, {Ali A.} and Akinnusi, {Morohunfolu E.} and Misha Peter and Ilya Berim and Schultz, {Marcus J.} and Lilibeth Pineda",
year = "2008",
month = "6",
doi = "10.1007/s00134-008-1087-7",
language = "English",
volume = "34",
pages = "1012--1019",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes

AU - El Solh, Ali A.

AU - Akinnusi, Morohunfolu E.

AU - Peter, Misha

AU - Berim, Ilya

AU - Schultz, Marcus J.

AU - Pineda, Lilibeth

PY - 2008/6

Y1 - 2008/6

N2 - Objective: To investigate the potential role of serum and alveolar soluble triggering receptor expressed on myeloid cells (sTREM-1) as a biological marker of pulmonary aspiration syndromes. Design: Prospective cohort study. Setting: University-affiliated intensive care unit. Patients: Seventy-five patients with pulmonary aspiration and 13 controls receiving mechanical ventilation. Interventions: Blood and bronchoalveolar lavage (BAL) fluid samples were collected on enrollment. Soluble TREM-1 levels were measured by an enzyme-linked immunosorbent assay. Measurements and results: Thirty-eight of 75 participants had documented BAL culture-positive pulmonary aspiration. While circulating levels of sTREM-1 were comparable between those with aspiration syndromes (19.81 ± 12.09 pg/ml) and controls (15.96 ± 11.16 pg/ml) (p = 0.27), the alveolar levels of sTREM-1 were higher in patients with culture-positive pulmonary aspiration (344.41 ± 152.82 pg/ml) compared with those culture-negative pulmonary aspiration (142.76 ± 89.88 pg/ml; p <0.001). A cut-off value of 250 pg/ml for alveolar sTREM-1 achieved a sensitivity of 65.8% (95% CI 48.6-80.4) and a specificity of 91.9% (95% CI 78.1-98.2) with an area under the curve of 0.87 (95% CI 0.78-0.94). Conclusions: Alveolar sTREM-1 levels can be a potential biomarker for distinguishing BAL culture-positive from BAL culture-negative pulmonary aspiration.

AB - Objective: To investigate the potential role of serum and alveolar soluble triggering receptor expressed on myeloid cells (sTREM-1) as a biological marker of pulmonary aspiration syndromes. Design: Prospective cohort study. Setting: University-affiliated intensive care unit. Patients: Seventy-five patients with pulmonary aspiration and 13 controls receiving mechanical ventilation. Interventions: Blood and bronchoalveolar lavage (BAL) fluid samples were collected on enrollment. Soluble TREM-1 levels were measured by an enzyme-linked immunosorbent assay. Measurements and results: Thirty-eight of 75 participants had documented BAL culture-positive pulmonary aspiration. While circulating levels of sTREM-1 were comparable between those with aspiration syndromes (19.81 ± 12.09 pg/ml) and controls (15.96 ± 11.16 pg/ml) (p = 0.27), the alveolar levels of sTREM-1 were higher in patients with culture-positive pulmonary aspiration (344.41 ± 152.82 pg/ml) compared with those culture-negative pulmonary aspiration (142.76 ± 89.88 pg/ml; p <0.001). A cut-off value of 250 pg/ml for alveolar sTREM-1 achieved a sensitivity of 65.8% (95% CI 48.6-80.4) and a specificity of 91.9% (95% CI 78.1-98.2) with an area under the curve of 0.87 (95% CI 0.78-0.94). Conclusions: Alveolar sTREM-1 levels can be a potential biomarker for distinguishing BAL culture-positive from BAL culture-negative pulmonary aspiration.

UR - http://www.scopus.com/inward/record.url?scp=46149100025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46149100025&partnerID=8YFLogxK

U2 - 10.1007/s00134-008-1087-7

DO - 10.1007/s00134-008-1087-7

M3 - Article

C2 - 18392807

AN - SCOPUS:46149100025

VL - 34

SP - 1012

EP - 1019

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 6

ER -